Placing Bioterrorism in its Context Dr. C. de Ville de Goyet.

Slides:



Advertisements
Similar presentations
Copyright 2004 Northrop Grumman Corporation 0 HIT Summit Leveraging HIT for Public Health Surveillance HIT Summit Leveraging HIT for Public Health Surveillance.
Advertisements

The Laboratory Response Network
For Official Use Only. Public Health and EMS How Long Do You Have to Live? For Official Use Only.
Early Warning System for CD Dr Venanzio Vella, Senior Epidemiologist, CEEN.
Alan J. Siniscalchi, MPH, MS Influenza & Bioterrorism Surveillance Coordinator State of Connecticut Department of Public Health & the International Society.
MINISTRY OF HEALTH ACTION PLAN FOR THE PREVENTION AND CONTROL OF ANTHRAX Dr. Marion BullockDuCasse, SMO(H) Director, Emergency, Disaster Management and.
Public Health Event Reporting: Lecture Template
Disease surveillance is an epidemiological practice by which.
1 Bioterrorism Presentation Sharon F. Grigsby, MBA Executive Director Bioterrorism Preparedness Program Public Health Department of Health Services County.
North Carolina’s Role in Preparedness. Objectives How you fit into the LRN Describe critical aspects of lab preparedness, surveillance and reporting,
Role of the laboratory in disease surveillance
Epidemiologic Preparedness and Response to Terrorist Events Involving the Nation’s Food Supply Jeremy Sobel, MD MPH Foodborne and Diarrheal Diseases Branch.
Early Warning System for CD Dr Venanzio Vella, Senior Epidemiologist, CEU.
New Jersey Experience and Protocol Development Teresa Hamby Infectious & Zoonotic Disease Program New Jersey Department of Health & Senior Services.
UNCLASSIFIED Building Biosurveillance Systems for Early Detection of Public Health Events Central Asia Regional Health Security Conference April.
The Laboratory Response Network
Surveillance Dona Schneider, PhD, MPH.  Surveillance is the ongoing, systematic collection, analysis, and interpretation of health data essential to.
Overview of ‘Syndromic Surveillance’ presented as background to Multiple Data Source Issue for DIMACS Working Group on Adverse Event/Disease Reporting,
Laboratory Response Network Spokane Regional Health District.
Influenza Surveillance at IRID Immunization and Respiratory Infections Division Centre for Infectious Disease Prevention & Control Public Health Agency.
Ohio Department of Health1 The State of Ohio Weapons of Mass Destruction BIO TERRORISM PROTOCOL PROCEDURES FOR LOCAL, STATE AND FEDERAL PERSONNEL AND AGENCIES.
Public Health Surveillance
Using Disease Surveillance and Response to Facilitate Adaptation to Climate- Related Health Risks Kristie L. Ebi, Ph.D., MPH Development Day at COP-11.
CDC Centers for Disease Control and Prevention Medical & Public Health to Bioterrorism: Challenges for Decisive Action 13 th World Congress on Disaster.
Surveillance Activities during Pandemic Phases Anne-Luise Winter APHEO-COMOH Workshop Toronto February 1, 2007.
Local Emergency Response to Biohazardous Incidents Dr. Elizabeth Whalen, MD Medical Director Albany County Health Department April 8, 2005 Northeast Biological.
Lauren Lewis, MD, MPH Health Studies Branch Environmental Hazards and Health Effects National Center for Environmental Health Centers for Disease Control.
Surveillance Overview Julia Gunn Boston Public Health Commission.
SEARO –CSR Early Warning and Surveillance System Module Case Definitions.
Influenza Surveillance Danae Bixler, MD, MPH Infectious Disease Epidemiology Program.
EPIDEMIOLOGY DENGUE, MALARIA Priority Areas for Planning Dengue Emergency Response 1. Establish a multisectoral dengue action committee.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
1 Copyright © 2012 by Mosby, an imprint of Elsevier Inc. Copyright © 2008 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 13 Infectious Disease Prevention.
Public Health Issues Associated with Biological and Chemical Terrorism Scott Lillibridge, MD Director Bioterrorism Preparedness and Response Activity National.
1 Biological Agents Slides will automatically advance seconds after clicking on start button.
Promoting Clinician Readiness Maureen Lichtveld, M.D., M.P.H. Associate Director for Workforce Development Public Health Practice Program Office/OD Centers.
Aaron Kite-Powell, MS Florida Department of Health Bureau of Epidemiology International Society of Disease Surveillance Webinar May 2009 Emergency Department-
The Vermont Department of Health Overview of Pandemic Influenza Regional Pandemic Planning Summits 2006 Guidance Support Prevention Protection.
Framing the Issue: FDA Perspective Product Tracing Sherri A. McGarry Center for Food Safety and Applied Nutrition Food and Drug Administration.
Using Informatics to Promote Community/Population Health
National Governors Association Policy Summit on Domestic Terrorism National Governors Association Policy Summit on Domestic Terrorism Tabletop Exercise.
Mr. C’s Joke/Riddle of the Day. The Role Canada is Playing How the World Keeps Diseases from Spreading Pt.2.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Is it Strategic Defense Initiative (SDI) – "Star War» ? No it is New Epi- demiological World- wide Strategic De- fense Initiative - (NEWSDI)
CDC Centers for Disease Control and Prevention Public Health &Bioterrorism European Diploma Course in Disaster Medicine Republic of San Marino 12 May,
The Delaware Electronic Reporting and Surveillance System (DERSS)
Public Health Laboratory Department of Public Health Ministry of Health National Early Warning Alert Response Surveillance (NEWARS) Sonam.
Text 1 End Text 1 Learning Module 5: Surveillance and Infection Control.
Community Health Nursing ASN 260 Chapter 12-Iggy Community Emergency Preparedness & response S. Tapp MSN BSN RN 1 ADN 260/RN 12.
ASDPE International Health Regulations (IHR 2005) Laboratory and Zoonosis update Dr Richard Brown, WHO Thailand Workshop on Laboratory Diagnosis for Zoonotic.
Disease Outbreak Maria del Rosario, MD, MPH Infectious Disease Epidemiology Program WVDHHR/BPH/DSDC February
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
1 Copyright © 2012 by Mosby, an imprint of Elsevier Inc. Copyright © 2008 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 24 Public Health Surveillance.
Rational Strategies Interventions of choiceInterventions of choice Economic, social and other non-medical countermeasures Interventions of last resortInterventions.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Companion Animal Veterinarians and Public Health Initiatives: Tools for Integrated Zoonotic Surveillance Diane M. Gubernot, M.P.H. Rebecca Parkin, Ph.D.,
Syndromic Surveillance and The Health Alert Network Lex Gibson Epidemiologist Alleghany/Roanoke City Health Districts.
Using Informatics to Promote Community/ Population Health
Outbreak Investigation
Understanding Epidemiology
Infectious Diseases Surveillance in the Military
Partnerships for Pandemic & Bioterrorism Incidents
Affiliation / Financial interest
Transitions in Public Health
Expert Panel: Todd Damrow Cheryl Juntunen Susan Keady Michael Skeels
North Carolina’s Role in Preparedness
Establishment of Influenza Surveillance System in Liberia
Anthrax, tularemia, plague, ebola or smallpox as agents of bioterrorism: recognition in the emergency room  B.A. Cunha  Clinical Microbiology and Infection 
Using Informatics to Promote Community/Population Health
North Carolina’s Role in Preparedness A Brief Overview
Presentation transcript:

Placing Bioterrorism in its Context Dr. C. de Ville de Goyet

The Anthrax great scare A demonstration of the superiority of informal reporting systemsA demonstration of the superiority of informal reporting systems Six deaths: A society overwhelmed with fearSix deaths: A society overwhelmed with fear Not a new threat!Not a new threat!

Anthrax Threats Reported to FBI Source: M. Lyons, CDC from FBI personal communication to Dr. Eric Noji

A critical look at some slides from CDC Most of the slides used are from Dr. Eric Noji Presentation at the PAHO Senior Managers Meetings in Nov Those slides have a blue background

Detection & surveillance Rapid laboratory diagnosis Epidemiologic investigations Implementation of control measures Public Health Response to… Bio-terrorism

Public Health Role in “Bioterrorism” “Detect and control the epidemic” Comments: Is it not the normal role of the Ministry of Health? Can you detect terrorist outbreaks without detecting first normal epidemics?

Early, rapid recognition of unusual clinical syndromes or deaths & of increase above “expected levels” of common syndromes, diseases, or death Rapid etiologic diagnosis Rapid response Bioterrorism Surveillance

Key features –Real time data  real time epidemiology –Syndrome-based reporting –Sentinel surveillance sites –Pro-active (high profile potential target events, ongoing surveillance in sentinel sites) –Reactive (monitoring and response) –Aberration Detection

Syndrome Surveillance The monitoring of illnesses based upon a constellation of symptoms and/or findings Provides an “early warning system” for outbreaks, emerging pathogens

Likely BT Agents: Initial Symptoms Agents –Anthrax –Plague –Q-fever –Tularemia –Smallpox Initial Symptoms –Fever –Cough –Malaise –Headache

Current Challenges Identification of localized clusters Sustainability of surveillance system Development of response protocols

Unanswered Questions What is the threshold that initiates response What is the sensitivity and specificity of surveillance systems Usefulness and feasibility of aggregate data from hospital admissions, ICD-9 codes on a large scale Do we have an answer to these questions for normal surveillance?

The “Unasked” Questions What is the real risk of terrorism act in the Caribbean?What is the real risk of terrorism act in the Caribbean? How much to invest (i.e. divert resources from other health priorities) for terrorism counter- measures?How much to invest (i.e. divert resources from other health priorities) for terrorism counter- measures? Cost-effectiveness?Cost-effectiveness?